Skip to content
INDUSTRY RELATIONS HUB LOGIN
PBM MEMBER PORTAL LOGIN
  • Areas of Focus
    • Value of PBMs
      • PBMs Create $145 Billion in Value Annually
    • Affordable Future
    • Biosimilars
    • Drug Pricing Issues
      • Smoke and Mirrors
      • Insulin
    • Health Equity
    • Patient Care
    • PBM Innovations
    • PBMs and Pharmacies
      • Pharmacy Market
      • PSAO Landscape
    • PBM Tools
      • PBM Tools
      • Encouraging Use of Generics and Affordable Brands
    • Rebates
    • Transparency
  • Newsroom
    • Press Releases and Blogs
    • Policy & Regulatory Insights
  • Research Hub
    • Rx Research Corner Blog
    • Research Feed
    • Infographics
  • About PCMA
    • PCMA Members
    • PCMA Leadership
    • PCMA Foundation
  • Drug Pricing Terms
  • PCMA Conferences
    • Conferences
Search
START TYPING AND PRESS ENTER TO SEARCH
  • Areas of Focus
    • Value of PBMs
      • PBMs Create $145 Billion in Value Annually
    • Affordable Future
    • Biosimilars
    • Drug Pricing Issues
      • Smoke and Mirrors
      • Insulin
    • Health Equity
    • Patient Care
    • PBM Innovations
    • PBMs and Pharmacies
      • Pharmacy Market
      • PSAO Landscape
    • PBM Tools
      • PBM Tools
      • Encouraging Use of Generics and Affordable Brands
    • Rebates
    • Transparency
  • Newsroom
    • Press Releases and Blogs
    • Policy & Regulatory Insights
  • Research Hub
    • Rx Research Corner Blog
    • Research Feed
    • Infographics
  • About PCMA
    • PCMA Members
    • PCMA Leadership
    • PCMA Foundation
  • Drug Pricing Terms
  • PCMA Conferences
    • Conferences
Search

MAC

Establishes criteria that must be followed when developing maximum allowable cost lists for generic drugs, including the frequency for updating the list, reimbursement appeals processes, and public transparency of the lists.
Filter by Document Type
Filters
Filters

     

    Issue Area
    Show (260)
    Cancel

    Forced Pharmacy Closure Legislative Analysis (Summary, 2025)

    View Document >

    2025 CA SB 41 Veto Request Comment Letter

    View Document >

    Federal Court Blocks Arkansas PBM Ownership Law, Citing Constitutional Violations (Mintz, 2025)

    View Document >

    Community Pharmacy Turnover and Context of Openings and Closings by Ownership Type (Mattingly, 2025)

    View Document >

    Specialty Pharmacies Are Designed to Advance Care (Talking Points, 2025)

    View Document >

    Restricting Pharmacy Benefit Manager (PBM) Affiliates Will Harm Patients and Impact Health Plan Design (Talking Points, 2025)

    View Document >

    2025 CA Assembly Approps SB 41 Comment Letter

    View Document >

    2025 IA SF 383 Comment Letter

    View Document >

    2025 VA Comment Letter to JCHC

    View Document >

    2025 CA SB 41 Comment Letter

    View Document >

    2025 DCBS DFR RAC Comment Letter

    View Document >

    2025 NJ A 4953 Testimony

    View Document >
    • Careers
    • Newsroom
    • PCMA Events
    • About PCMA
    • Member Login
    • How PBMs Work

    Media Contact

    Greg Lopes

    Vice President, Public Affairs

    • glopes@pcmanet.org
    • 202-756-5713

    Pharmaceutical Care
    Management Association

    505 9th Street NW, 10th Floor, Washington, DC 20004

    © 2025 PCMA. All Rights Reserved.
    • Privacy Policy
    • Terms of Use
    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT